2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home »
- Clinical Resources Search »
- PQI Podcast S6 Ep 7: Urology Clinic Best Practices
S6 Eps 7: Urology Clinic Best Practices
Last Updated: February 29, 2024
By: Ginger Blackmon, PharmD | Melanie Boren MHA, RN, BSN, OCN | Robin Carr
In this episode, we welcome the dynamic duo from Central Ohio Urology Group, Melanie Boren MHA, RN, BSN, OCN, and Robin Carr. Join us as they dive into how their multidisciplinary team collaborates to deliver top-tier patient care.
Melanie is the Director of Oncology Operations at Central Ohio Urology Group. She has worked in the oncology setting for 25 years. Robin is the Lead Pharmacy Tech at Central Ohio Urology Group. She oversees all dispensing of medications at two locations and has been a Pharmacy Technician for 35 years.
Related Content
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E2: Love Languages in Cancer Care
Author: Ginger Blackmon, PharmD | Jenny Hoang, PharmD
Last Updated: 09/09/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 09/09/2025
S8 Bonus Eps 2: Inside ASCO 2025
Author: Ginger Blackmon, PharmD | Kelly Brunk, PharmD, BCOP
Last Updated: 09/09/2025
S8 E15: Supporting Survivors at Work
Author: Ginger Blackmon, PharmD | Rebecca Nellis, MPP
Last Updated: 09/09/2025
PQI
PQI
PQI
PQI
PQI: Use of Rucaparib (Rubraca®) and Indications
Author: Jon Suyko Pharm.D., BCPS
Last Updated: 09/09/2025
PQI: Talazoparib (Talzenna®) and Enzalutamide (Xtandi®) in HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Author: Kathleen Burns, MSN, NP
Last Updated: 09/09/2025
PQI: Radium Ra 223 Dichloride (Xofigo®) Management
Author: Jill Boyett, PharmD, CPh
Last Updated: 09/09/2025
PQI: Olaparib (Lynparza®) Clinical Management
Author: Katie Carter, PharmD, BCPS
Last Updated: 09/09/2025
PQI
PQI
PQI in Action
PQI in Action
PQI: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 09/09/2025
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 09/09/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 09/09/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 09/09/2025
PQI Podcast
PQI
PQI
PQI Podcast
S9 E2: Love Languages in Cancer Care
Author: Ginger Blackmon, PharmD | Jenny Hoang, PharmD
Last Updated: 09/09/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Author: Tracelyn Freeman, PharmD, BCOP
Last Updated: 09/09/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/09/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 09/09/2025